Kenvue (J&J spinoff) makes Tylenol, Band-Aid, Neutrogena and Listerine.
Kenvue Inc. (KVUE) is expected to report earnings on Monday, November 2, 2026, after the close. Estimated release time 06:48 ET. Consensus EPS estimate is $0.29.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | Jun 2026 qtr | $0.32 | $0.31 | -2.7% | $3.96B |
| 2026-05-07 | Mar 2026 qtr | $0.26 | $0.32 | +22.1% | $3.91B |
| 2026-02-20 | Dec 2025 qtr | $0.22 | $0.27 | +21.2% | $3.78B |
| 2025-11-03 | Sep 2025 qtr | $0.26 | $0.28 | +7.6% | $3.76B |
| 2025-08-07 | Jun 2025 qtr | $0.28 | $0.29 | +2.9% | $3.84B |
| 2025-05-08 | Mar 2025 qtr | $0.23 | $0.17 | — | $3.74B |
| 2025-02-24 | Dec 2024 qtr | $0.26 | $0.15 | — | $3.66B |
| 2024-11-07 | Sep 2024 qtr | $0.27 | $0.20 | — | $3.90B |
KVUE has beaten consensus EPS in 4 of its last 5 scored quarters.
KVUE pays a monthly dividend, currently yielding 5.90%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-09-21 | $0.21 | 2026-10-02 |
| 2026-08-12 | $0.21 | 2026-08-26 |
| 2026-05-13 | $0.2075 | 2026-05-27 |
| 2026-02-11 | $0.2075 | 2026-02-25 |
| 2025-11-12 | $0.2075 | 2025-11-26 |
| 2025-08-13 | $0.2075 | 2025-08-27 |